Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Retinoblastoma

Below is an extended Retinoblastoma patents listing. Click here to return to the Retinoblastoma main in depth entry.

Patents :

US Patent No.Title
7599745 Treating a tumor or the like with an electric field
7604939 Methods of identifying active BRM expression-promoting HDAC inhibitors
7605138 Nucleic acid compositions for stimulating immune responses
7605144 Enzyme catalyzed therapeutic compounds
7605156 Methods for the use of inhibitors of cytosolic phospholipase A2
7605175 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
7605236 Antibodies that immunospecifically bind to B lymphocyte stimulator protein
7605266 Azaindole inhibitors of Aurora kinases
7607776 Digital eye bank for virtual clinic trials
7608255 Replication-competent anti-cancer vectors
7604936 Methods and compositions for diagnosis and monitoring auto immune and chronic inflammatory diseases
7604799 EphA4 Antibodies
7601739 Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
7599933 Coupled two-way clustering analysis of data
7600343 Method of stimulating plant growth
7601355 Compositions and methods for altering immune function
7601359 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
7601533 Reverse two-hybrid systems
7601534 Method for multiplying stem cells
7601700 Modulation of eIF4E expression
7601703 Enzyme catalyzed therapeutic agents
7601719 Compounds, methods and pharmaceutical compositions for inhibiting PARP
7608259 Methods of cancer diagnosis and therapy targeted against a cancer stem line
7608260 Stabilized immunoglobulins
7608267 Multifunctional cytokines
7612079 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders
7612178 Anti-IGF-1R antibodies and uses thereof
7612201 Pyrazole compounds
7612255 Transgenic plants for mitigating introgression of genetically engineered genetic traits
7615223 Selected immunoconjugates for binding to aminophospholipids
7615379 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
7615380 Methods for modulating an immune response by modulating KRC activity
7615554 Erastin and erastin binding proteins, and uses thereof
7615628 Imidazopyridine derivatives
7611879 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
7611838 Biologically-active DNA-binding sites and related methods
7611704 Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
7608392 Diagnostic assay for measuring a cell mediated immune response
7608394 Methods and compositions for phenotype identification based on nucleic acid methylation
7608591 Targeted delivery to legumain-expressing cells
7608618 Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
7608635 Pyrazole compounds that modulate HSP90 activity
7608643 Compounds for inhibiting KSP kinesin activity
7608683 Stress proteins and peptides and methods of use thereof
7608723 Indole and benzimidazole derivatives
7608739 Mitotic kinesin inhibitors
7615634 4-aminopyrimidine-5-one derivatives

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.